Late night bad sudden!
On February 14, Andon Health Co.Ltd(002432) announced that the company recently received the decision on administrative supervision measures issued by Tianjin Securities Regulatory Bureau. Andon Health Co.Ltd(002432) only some successful test results were disclosed on January 7, 2022, but all the test results were not disclosed, and the disclosure information was incomplete. As the chairman and general manager of Andon Health Co.Ltd(002432) and Wu Tong as the Secretary of Andon Health Co.Ltd(002432) board of directors, Liu Yi is mainly responsible for the integrity of information disclosure in the interim report of listed companies. Tianjin Bureau has decided to take supervision and management measures for the two of you. Previously, Andon Health Co.Ltd(002432) rose nearly 14 times in less than three months, making it the strongest demon stock in the next year.
Another stock Ningbo Sunlight Electrical Appliance Co.Ltd(002473) with strong stock rise was in breach of contract due to the stock pledge business handled by its major shareholder Jin Yangguang, First Capital Securities Co.Ltd(002797) from January 25, 2022 to February 11, 2022, sold 984600 shares of the company held by Jin Yangguang (accounting for 0.62% of the total share capital of the listed company) through the secondary market, and may continue to sell. The stock rose against the market limit on Monday.
\u3000\u3000
Andon Health Co.Ltd(002432) burst
It was announced on February 14 that the company recently received a decision on administrative supervision measures (hereinafter referred to as the “decision”) issued to the company by Tianjin regulatory bureau of China Securities Regulatory Commission (hereinafter referred to as “Tianjin Securities Regulatory Bureau”).
The contents of the decision are as follows:
I. decision on taking regulatory talk measures against Liu Yi and Wu Tong
After investigation, on January 7, 2022, Andon Health Co.Ltd(002432) (hereinafter referred to as Andon Health Co.Ltd(002432) or the company) disclosed that on January 5, 2022 Beijing time, the company received the performance test report of the Radx project of the National Institutes of Health (NIH) on the household self-test OTC kit of ihealth covid-19 antigen against Omicron mutant virus arranged by the FDA, The report also said that “the ihealth-covid-19 antigen rapid test detected 100% of Omicron active virus samples with a maximum CT value of 21.59 (n = 5)”. On January 15, 2022, when replying to the letter of concern from Shenzhen Stock Exchange, the company said that “100% of Omicron active virus samples with a maximum CT value of 21.59 (n = 5) were detected in the experiment”, in which “maximum” means that samples less than or equal to 21.59 can be detected 100%, and samples greater than 21.59 cannot be detected 100%, It also said that “the positive detection rate of all samples in the experimental group: when the CT value is ≤ 21.59, it can be detected completely, when the CT value is 22.86, it can be detected 60%, and when the CT value is ≥ 23.87, it can not be detected at all.” Andon Health Co.Ltd(002432) only some successful test results were disclosed on January 7, 2022, but all the test results were not disclosed, and the disclosure information was incomplete.
As the chairman and general manager of Andon Health Co.Ltd(002432) and Wu Tong as the Secretary of Andon Health Co.Ltd(002432) board of directors, Liu Yi is mainly responsible for the integrity of information disclosure in the interim report of listed companies. During your tenure, you two failed to faithfully and diligently perform your duties, in violation of Article 4 of the measures for the administration of information disclosure of listed companies. In accordance with the provisions of articles 51 and 52 of the measures for the administration of information disclosure of listed companies, our bureau has decided to take supervision and management measures for the two of you, and ask you to bring valid ID cards to our bureau for supervision and conversation before February 18, 2022.
If you are not satisfied with the supervision and administration measures, you can apply for administrative reconsideration to the China Securities Regulatory Commission within 60 days from the date of receiving the decision, or you can bring a lawsuit to the people’s court with jurisdiction within 6 months from the date of receiving the decision. During the period of reconsideration and litigation, the above supervision and management measures shall not be suspended.
II. Relevant instructions
Andon Health Co.Ltd(002432) and relevant personnel attach great importance to the above administrative supervision measures, and will actively rectify in strict accordance with the supervision requirements, carefully summarize and draw lessons, strengthen the learning of relevant personnel on securities laws and regulations, and strengthen the awareness of standardized operation; At the same time, strengthen internal control and information disclosure management, effectively improve the standard operation level and information disclosure quality of the company, safeguard the interests of the company and all shareholders, and promote the healthy, stable and sustainable development of the company. The above administrative supervision measures have no significant impact on the operation of the company. Please invest rationally and pay attention to investment risks.
Recently, Andon Health Co.Ltd(002432) showed weak performance. It once fell to the limit on Friday and continued to fall sharply on Monday, with a turnover of more than 4 billion yuan. According to Andon Health Co.Ltd(002432) disclosure, in the teleconference surveyed by the organization on February 10, in view of the company’s operation in the United States, the company said that at present, the tension between supply and demand has been alleviated, and the company’s current delivery schedule has been shortened. According to the current production schedule, it will be able to meet the needs of government and commercial customers as planned, and the new cases announced in the United States have been reduced compared with the previous period, There are also cases where the self-test with the kit is not reported actively and is not counted.
Ningbo Sunlight Electrical Appliance Co.Ltd(002473) forced flat
Ningbo shenglai received an email notice from the company’s shareholder Ningbo Golden Sunshine electrothermal Technology Co., Ltd. (hereinafter referred to as “Golden Sunshine”) on February 14, 2022:
Due to the breach of the stock pledge business handled by jinyangguang, First Capital Securities Co.Ltd(002797) sold 984600 shares of the company held by jinyangguang (accounting for 0.62% of the total share capital of the listed company) through the secondary market from January 25, 2022 to February 11, 2022, and may continue to close positions in the future.
The stock rose against the market limit on Monday, more than tripled in the last year, and is still in a strong pattern. According to its financial data, the company has suffered losses for two consecutive years and will be delisted if it continues to suffer losses in 2021. On January 5, the company disclosed that 33.859 million yuan of funds raised by the company were forcibly transferred by Ningbo intermediate people’s court and the account balance was “zero” due to the dispute over the liability of Securities Misrepresentation.
According to the delisting rules, if the net profit of the company in 2021 is negative, the revenue is less than 100 million yuan, the net assets at the end of the period are negative, and the financial report is issued with non-standard opinions, the listing and trading of the shares will be terminated. As of the third quarter, the net assets of the company were 17.38 million yuan, and the net profit attributable to the shareholders of the listed company from January to December 2021 was expected to be 42 million yuan to 58 million yuan, turning losses into profits year-on-year.
However, it remains to be seen whether these financial practices meet the shell preservation requirements of transactions.
